HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 793-804 of 4,505
Drug study icon
CompletedNCT00206570

Clinical Estradiol study in Women With Schizophrenia

Official study title

Double Blind Study of Estradiol Plus Neuroleptic Versus Placebo Plus Neuroleptic in the Treatment of Psychotic Symptoms in Women With Schizophrenia

This study has finished and is no longer accepting participants.

In Melbourne
SchizophreniaMedication studyAges 18–45
Countries
Australia
Sponsor
Bayside Health
Behavioral study icon
CompletedNCT02360813

Cognitive Remediation Therapy Within a Secure Forensic Setting

Official study title

Randomised Controlled Trial to Evaluate the Efficacy of Cognitive Remediation Within a Secure Forensic Setting for Schizophrenia Spectrum Patients

This study has finished and is no longer accepting participants.

In Dublin
SchizophreniaBehavioural studyAges 18–65
Countries
Ireland
Sponsor
Central Mental Hospital
Behavioral study icon
CompletedNCT04902066

Face Your Fears: Cognitive Behavioural Virtual Reality Therapy for "Paranoia".

What is this study about?

This study evaluated the effectiveness of cognitive behavioural therapy for people with schizophrenia.

This study has finished and is no longer accepting participants.

In Copenhagen
SchizophreniaInterventional studyAges 18+
Countries
Denmark
Sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Drug study icon
CompletedNCT01450514

POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia

Official study title

POC Study of Pipamperone 15mg Added to Stable Risperidone or Paliperidone Treatment in Chronic Schizophrenic and Schizoaffective Patients With Residual Symptoms: a Phase I/IIa, Randomized, Double-blind, Placebo-controlled Trial of 7 Weeks

This study has finished and is no longer accepting participants.

In Kortenberg
SchizophreniaMedication studyAges 18–65
Countries
Belgium
Sponsor
PharmaNeuroBoost N.V.
Other study type icon
TerminatedACTRN12616001499471

A study measuring a new clinical psychology intervention on improving outcomes for people with schizophrenia and distressing voice hallucinations.

Official study title

A single blind randomised controlled clinical trial testing the effectiveness of a clinical psychology intervention on improving the distress associated with auditory hallucinations in schizophrenia as measured by the Revised Beliefs About Voices Questionnaire.

This study ended early.

In Nedlands
SchizophreniaInterventional studyAges 18–65
Countries
Australia
Sponsor
North Metropolitan Health Service -Adult Mental Health

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.